Showing results (141-150 of 237) with videos related to

Sort By:
Pageof 24
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 17, 2001
Na,K-atpase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parametersA Djemli-Shipkolye, T Coste, D Raccah, et al.
Annales De Biologie Clinique|January 1, 1995
[Evaluation of assay methods of glycohemoglobin: reference method and parameter]P Gillery, M Delpech, I Garcia, et al.
The Journal of Membrane Biology|January 18, 2003
Differential effect of omega3 PUFA supplementations on Na,K-ATPase and Mg-ATPase activities: possible role of the membrane omega6/omega3 ratioA Djemli-Shipkolye, D Raccah, G Pieroni, et al.
Haemostasis|January 13, 2001
Formation, inhibition and clearance of plasmin in vivoW L Chandler, M C Alessi, M F Aillaud, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|January 27, 2005
Peripheral diabetic neuropathy and polyunsaturated fatty acid supplementations: natural sources or biotechnological needs?T C Coste, A Gerbi, P Vague, et al.
Thrombosis and Haemostasis|February 28, 1984
Effect of 24 hours of normoglycaemia on tissue-type plasminogen activator plasma levels in insulin-dependent diabetesI Juhan-Vague, P Vague, C Poisson, et al.
Journal of Diabetes and Its Complications|June 9, 1998
Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic ratsD Raccah, T Coste, N E Cameron, et al.
The British Journal of Nutrition|July 27, 2000
Dietary fat clearance in type V hyperlipoproteinaemia secondary to a rare variant of human apolipoprotein E: the apolipoprotein E3 (Arg 136-->Ser)B Vialettes, P Reynier, C Atlan-Gepner, et al.
Metabolism: Clinical and Experimental|March 12, 2002
Genetic and environmental regulation of Na/K adenosine triphosphatase activity in diabetic patientsM F Jannot, D Raccah, D Dufayet De La Tour, et al.
Diabetes Care|November 5, 1998
Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of ObesityM A Charles, P Morange, E Eschwège, et al.
Pageof 24